NIH Grant Approvals Decelerate Further in Trump’s Second Year Amid Screening Push and Staffing Shortages

In the second year of the Trump administration, the National Institutes of Health announced that the number of newly approved research grants had fallen to a level markedly lower than in any recent fiscal cycle, a decline that has been quantified as a continued deceleration relative to the agency’s historically upward‑trend trajectory. The agency’s quarterly report, released on April 22, 2026, placed the slowdown within a broader pattern of fiscal restraint that appears to be reinforced not merely by budgetary decisions but also by an intensified internal policy to flag and reject proposals containing terminology deemed politically undesirable.

According to internal communications, the renewed effort to screen grant applications for disfavored terms, a practice that has been revived after a period of relative leniency, now subjects each submission to multiple layers of linguistic review, thereby extending processing times and inadvertently narrowing the pool of fundable projects. Compounding this procedural bottleneck, the agency has experienced a substantive loss of experienced grant‑administration personnel over the past twelve months, a depletion that officials attribute to a combination of retirements, attrition driven by reduced morale, and a hiring freeze that has left critical review positions vacant for extended periods.

The confluence of an ideologically driven lexical filter and a deteriorating workforce thus exposes a systemic inconsistency whereby the NIH’s mandate to accelerate biomedical discovery is undermined by internal mechanisms that prioritize compliance over scientific merit, a paradox that reviewers and investigators alike have begun to regard as an inevitable byproduct of the current administrative climate. Observers note that unless the agency reconciles its funding cadence with a transparent, expertise‑driven review process and restores sufficient staffing levels, the observed slowdown is likely to persist, thereby further distancing the United States from its proclaimed leadership in global health research.

Published: April 22, 2026